Role of the PI3K/Akt, mTOR, and STK11/LKB1 pathways in the tumorigenesis of sclerosing hemangioma of the lung

Pathology International

Volumn 58, Issue 1, 2008, Pages 38-44

  Amin, Randa M S ^a,b   Hiroshima, Kenzo ^a   Miyagi, Yohei ^c   Kokubo, Takeshi ^b   Hoshi, Kazuei ^b   Fujisawa, Takehiko ^a   Nakatani, Yukio ^a  

^a CHIBA UNIVERSITY   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

Author keywords

HIF 1 ; mTOR; PTEN; Sclerosing hemangioma; STK11; TSC; VEGF

Indexed keywords

HAMARTIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN KINASE LKB1; PROTEIN S6; TUBERIN; VASCULOTROPIN;

ARTICLE; CARCINOGENESIS; CHROMOSOME 10; CONTROLLED STUDY; ENZYME MECHANISM; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PULMONARY SCLEROSING HEMANGIOMA; SOMATIC MUTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY SCLEROSING HEMANGIOMA; SIGNAL TRANSDUCTION;

EID: 36649023100     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02186.x     Document Type: Article

References (34)

1. Liebow AA, Hubbell DS. Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer 1956 9 : 53 75.
2. Nagata N, Dairaku M, Ishida T, Sueishi K, Tanaka K. Sclerosing hemangioma of the lung. Immunohistochemical characterization of its origin as related to surfactant apoprotein. Cancer 1985 55 : 116 23.
3. Satoh Y, Tsuchiya E, Weng SY et al. Pulmonary sclerosing hemangioma of the lung. A type II pneumocytoma by immunohistochemical and immunoelectron microscopic studies. Cancer 1989 64 : 1310 17.
4. Yoo SH, Jung KC, Kim JH et al. Expression patterns of markers for type II pneumocytes in pulmonary sclerosing hemangiomas and fetal lung tissues. Arch Pathol Lab Med 2005 129 : 915 19.
5. Wang E, Lin D, Wang Y, Wu G, Yuan X. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. Hum Pathol 2004 35 : 503 8.
6. Illei PB, Rosai J, Klimstra DS. Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung. Arch Pathol Lab Med 2001 125 : 1335 9.
7. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol 2000 24 : 906 16.
8. Niho S, Suzuki K, Yokose T, Kodama T, Nishiwaki Y, Esumi H. Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol 1998 152 : 1065 9.
9. Muir TE, Leslie KO, Popper H et al. Micronodular pneumocyte hyperplasia. Am J Surg Pathol 1998 22 : 465 72.
10. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004 18 : 1926 45.
11. Tee AR, Blenis J. mTOR, translational control and human disease. Semin Cell Dev Biol 2005 16 : 29 37.
12. Kwiatkowski DJ, Manning BD. Tuberous sclerosis: A GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005 14 : R251 8.
13. Marignani PA. LKB1, the multitasking tumour suppressor kinase. J Clin Pathol 2005 58 : 15 19.
14. Esteller M, Avizienyte E, Corn PG et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 2000 19 : 164 8.
15. Corradetti MN, Inoki K, Bardeesy N, DePinho RA, Guan KL. Regulation of the TSC pathway by LKB1: Evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 2004 18 : 1533 8.
16. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999 96 : 4240 45.
17. Hudson CC, Liu M, Chiang GG et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002 22 : 7004 14.
18. Sumiyoshi Y, Kakeji Y, Egashira A, Mizokami K, Orita H, Maehara Y. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 2006 12 : 5112 17.
19. Qiu W, Schonleben F, Thaker HM, Goggins M, Su GH. A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene 2006 25 : 2937 42.
20. Scott RJ, Crooks R, Meldrum CJ et al. Mutation analysis of the STK11/LKB1 gene and clinical characteristics of an Australian series of Peutz-Jeghers syndrome patients. Clin Genet 2002 62 : 282 7.
21. Sanchez-Cespedes M, Parrella P, Esteller M et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 2002 62 : 3659 62.
22. Ghaffar H, Sahin F, Sanchez-Cepedes M et al. LKB1 protein expression in the evolution of glandular neoplasia of the lung. Clin Cancer Res 2003 9 : 2998 3003.
23. Conde E, Suarez-Gauthier A, Garcia-Garcia E et al. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas. Hum Pathol 2007 38 : 1351 60.
24. Rowan A, Churchman M, Jefferey R, Hanby A, Poulsom R, Tomlinson I. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J Pathol 2000 192 : 203 6.
25. Han S, Khuri FR, Roman J. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer Res 2006 66 : 315 23.
26. Iyoda A, Hiroshima K, Shiba M et al. Clinicopathological analysis of pulmonary sclerosing hemangioma. Ann Thorac Surg 2004 78 : 1928 31.
27. Perren A, Weng LP, Boag AH et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999 155 : 1253 60.
28. Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 2005 19 : 1773 8.
29. Plank TL, Logginidou H, Klein-Szanto A, Henske EP. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol 1999 12 : 539 45.
30. Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999 59 : 5830 35.
31. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006 70 : 1469 80.
32. Ylikorkala A, Rossi DJ, Korsisaari N et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science 2001 293 : 1323 6.
33. Couvelard A, O'Toole D, Leek R et al. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology 2005 46 : 668 76.
34. Yoshiji H, Kuriyama S, Noguchi R et al. Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. Hepatol Res 2006 36 : 124 9.